Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - TAX PROVISION
Tax Provision ANVS - Annovis Bio, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR